FINA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on Finance (FINA)

43rd Parliament, 2nd Session

Meeting 33

Tuesday, April 13, 2021, 4:00 p.m. to 6:32 p.m.

Room 025-B, West Block

Televised

Presiding

Hon. Wayne Easter, Chair (Liberal)

Expand All Collapse All

Members of the Committee present

Liberal

Conservative

Bloc Québécois

Gabriel Ste-Marie

Acting Members present

• Gord Johns for Peter Julian (NDP)

Other Members present

• Elizabeth May (Green Party)

In attendance

Library of Parliament

• Brett Capwell, Analyst

• Michaël Lambert-Racine, Analyst

COVID-19 Spending, Programs, and Related Monetary Policy

Witnesses

BGC Canada

• Josh Berman, Director, Research and Public Policy

• Chad Polito, Executive Director, BGC Dawson, Montreal

Big Brothers Big Sisters of Canada

• W. Matthew Chater, National President and Chief Executive Officer

• Margie Grant-Walsh, Executive Director, Big Brothers Big Sisters of Pictou County

Coalition Canada Basic Income

• Barbara Boraks, Member

Festivals and Major Events Canada

• Martin Roy, Executive Director

Canadian Aquaculture Industry Alliance

• Tim Kennedy, President and Chief Executive Officer

Canadian Chamber of Commerce

• Trevin Stratton, Chief Economist and Senior Vice-President, Policy

• Alla Drigola, Director, Parliamentary Affairs and Small and Medium Enterprises Policy

Canadian Women's Chamber of Commerce

• Nancy Wilson, Founder and Chief Executive Officer

• Petra Kassün-Mutch, Board Member

Providence Therapeutics

• Brad Sorenson, Chief Executive Officer

Pursuant to Standing Order 108(2) and the motion adopted by the committee on Friday, February 5, 2021, the committee resumed its study of the COVID-19 Spending, Programs, and Related Monetary Policy.

Josh Berman, Chad Polito, W. Matthew Chater, Margie Grant-Walsh, Barbara Boraks, and Matin Roy made statements and answered questions.

At 5:19 p.m., the sitting was suspended.

At 5:23 p.m., the sitting resumed.

Tim Kennedy, Trevin Stratton, Alla Drigola, Nancy Wilson, and Brad Sorenson made statements and, with Petra Kassün-Mutch, answered questions.

At 6:32 p.m., the committee adjourned to the call of the Chair.

Alexandre Roger

Clerk of the Committee